AECOM
ACM
$69.95
-12.01%
AECOM is a global leader in providing advisory, design, and engineering services across critical infrastructure end markets such as water, transportation, and the environment. The company operates as a dominant, integrated professional services firm, leveraging its scale and technical expertise to secure large-scale, complex projects worldwide. The current investor narrative is dominated by a significant stock price decline following its Q1 FY2026 earnings report, which revealed a revenue contraction and a sharp drop in profitability, raising concerns about near-term execution and the impact of macroeconomic headwinds on its project pipeline.…
ACM
AECOM
$69.95
Investment Opinion: Should I buy ACM Today?
Rating: Hold. The core thesis is that ACM is a fundamentally sound company experiencing a severe but likely transient operational setback, making the current price a fair entry point for patient, value-oriented investors but lacking a near-term catalyst for a decisive rally.
The Hold rating is supported by four key data points: 1) The compelling forward P/E of 12.71x, which prices in a significant earnings recovery, 2) The robust $616 million in TTM free cash flow that provides a financial safety net, 3) The analyst EPS target of $7.52 for FY2026, implying 1218% growth from Q1 levels and offering a clear fundamental benchmark, and 4) The stock's proximity to its 52-week low, suggesting limited near-term downside. However, the elevated trailing P/E of 30.74x and the -4.6% YoY revenue growth temper enthusiasm.
The two biggest risks invalidating this thesis are: 1) A failure to arrest the margin decline in the next quarter, and 2) A further deterioration in the revenue backlog. This Hold would upgrade to a Buy if the forward P/E compresses further toward 10x (stock price ~$75) on sustained FCF, or if Q2 results show sequential margin improvement. It would downgrade to a Sell if revenue growth turns more negative (below -5% YoY) or if FCF generation materially weakens. The stock is fairly valued relative to its depressed near-term prospects but undervalued if the analyst recovery forecast is accurate.
Sign up to view all
ACM 12-Month Price Forecast
ACM presents a classic 'show me' story at a fair price. The valuation is not demanding if a recovery occurs, but the fundamental deterioration in Q1 was too severe to ignore, justifying the market's punitive response. The high free cash flow and low forward P/E create a favorable risk/reward setup for contrarians, but the burden of proof is squarely on management to demonstrate the Q1 miss was an anomaly. The stance would upgrade to Bullish on evidence of sequential margin improvement in the next quarterly report; it would turn Bearish if revenue declines accelerate or FCF weakens materially. The base case of a slow, grinding recovery is most probable.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on AECOM's 12-month outlook, with a consensus price target around $90.94 and implied upside of +30.0% versus the current price.
Average Target
$90.94
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$56 - $91
Analyst target range
Analyst coverage data is limited, with only one analyst providing estimates, indicating insufficient coverage for a robust consensus view; this limited institutional following can lead to higher volatility and less efficient price discovery for this mid-cap industrial stock. The single analyst estimates fiscal 2026 EPS of $7.52, with a range from $7.17 to $7.86, and revenue of $8.86 billion; the high EPS target likely assumes a swift margin recovery and backlog conversion, while the low end may factor in continued project delays or cost pressures. Recent institutional ratings from firms like RBC Capital (Outperform), UBS (Buy), and Barclays (Equal Weight) show a generally bullish tilt, but the downgrade of Barclays from Overweight to Equal Weight in December 2025 aligns with the emerging fundamental concerns witnessed in the Q1 report.
Bulls vs Bears: ACM Investment Factors
The bear case currently holds stronger evidence, anchored by the severe, quantifiable deterioration in Q1 fundamentals—a 55% drop in net income and a 4.6% revenue decline. The bull thesis rests almost entirely on a forecasted earnings recovery priced into a low forward P/E of 12.71x and strong underlying free cash flow. The single most important tension in the investment debate is whether the Q1 collapse represents a temporary, project-specific execution issue or the beginning of a sustained downturn in ACM's core infrastructure markets. The resolution of this question, visible in subsequent quarterly margins and backlog figures, will determine if the stock is a deep-value opportunity or a value trap.
Bullish
- Strong Free Cash Flow: ACM generated $616 million in trailing twelve-month free cash flow, providing significant financial flexibility to navigate the current downturn. This robust cash generation supports the dividend and potential share repurchases, insulating the balance sheet from the near-term earnings shock.
- Attractive Forward Valuation: The forward P/E of 12.71x is compelling, representing a steep discount to the trailing P/E of 30.74x and implying the market expects a significant earnings recovery. This valuation is reasonable for a capital-light services business, with an EV/Sales of 0.83 and a PEG ratio of 0.72 suggesting growth is not fully priced in.
- Analyst EPS Recovery Forecast: The single analyst covering ACM forecasts FY2026 EPS of $7.52, a massive recovery from the depressed Q1 EPS of $0.57. The high-end target of $7.86 implies a swift return to historical profitability levels, providing a clear fundamental catalyst for a re-rating if achieved.
- Technical Support Near Lows: The stock is trading at $84.1, just 6.4% above its 52-week low of $79.01, suggesting most negative news is priced in. With a -37.4% decline over six months and a -11.85 relative strength figure, the severe underperformance creates a potential setup for a mean reversion bounce on any positive fundamental development.
Bearish
- Severe Profitability Collapse: Q1 FY2026 net income plummeted 55% YoY to $74.5 million, with net margin collapsing to 1.95% from 4.16%. Gross margin also weakened sequentially to 7.33% from 7.74%, indicating deep-seated operational issues beyond mere revenue softness.
- Revenue Contraction & Growth Stall: Q1 revenue declined 4.6% YoY to $3.83 billion, a sharp reversal from prior stability and signaling potential pressure on the project backlog. This contraction, coupled with a sequential drop from Q4's $4.18 billion, raises red flags about near-term business momentum and new win rates.
- Elevated Trailing P/E Amid Downturn: A trailing P/E of 30.74x is exceptionally high for a company with contracting profits and revenue, trading at a premium to the sector. This indicates valuation compression has lagged the earnings decline, leaving the stock vulnerable to multiple contraction if the recovery is delayed.
- Extreme Technical Downtrend: The stock has suffered a 37.4% collapse over six months and a 40.18% maximum drawdown, breaking key support levels. Trading at just 38% of its 52-week range signals persistent selling pressure and a complete loss of investor confidence, which can become a self-fulfilling prophecy.
ACM Technical Analysis
The stock is in a pronounced and sustained downtrend, having declined 37.40% over the past six months and 16.11% over the past year. With a current price of $84.1, it is trading at just 38% of its 52-week range ($79.01 to $135.52), positioning it near its lows and signaling deep investor pessimism, which could represent a potential value trap if fundamentals continue to deteriorate. Recent momentum shows a slight deceleration in the sell-off but remains negative, with the stock down 1.87% over the past month and 12.79% over the past three months; this divergence from the broader market is stark, as evidenced by a -11.85 relative strength figure over one month, indicating severe underperformance. Key technical support is firmly established at the 52-week low of $79.01, while resistance lies at the recent breakdown level near $135.52; a breach below $79 could trigger another leg down, while a sustained move above this year's high is unlikely without a fundamental catalyst. The stock's beta of 1.085 suggests it is only marginally more volatile than the market, yet its 40.18% maximum drawdown highlights the extreme idiosyncratic risk it has recently exhibited.
Beta
—
—
Max Drawdown
-47.9%
Largest decline past year
52-Week Range
$69-$136
Price range past year
Annual Return
-34.2%
Cumulative gain past year
| Period | ACM Return | S&P 500 |
|---|---|---|
| 1m | -16.3% | +8.6% |
| 3m | -30.7% | +6.7% |
| 6m | -47.7% | +9.8% |
| 1y | -34.2% | +26.6% |
| ytd | -27.4% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ACM Fundamental Analysis
Revenue growth has stalled and turned negative, with Q1 FY2026 revenue of $3.83 billion representing a 4.6% year-over-year decline; this marks a significant deceleration from the prior quarter's $4.18 billion in revenue and reverses a multi-quarter trend of stability, indicating potential pressure on the company's backlog and new wins. Profitability has contracted sharply, with Q1 net income plummeting to $74.5 million from $167.0 million in the year-ago quarter, and the net margin compressing to 1.95% from 4.16%; the gross margin also weakened to 7.33% from 7.74% in the prior quarter (Q4 FY2025), reflecting potential cost inflation or unfavorable project mix. The balance sheet shows moderate leverage with a debt-to-equity ratio of 1.35, but the company maintains solid liquidity with a current ratio of 1.14; critically, trailing twelve-month free cash flow is a robust $616 million, providing financial flexibility to navigate the downturn, though the Q1 operating cash flow of $70.2 million was a significant sequential drop from the $196.1 million generated in Q4 FY2025.
Quarterly Revenue
$3.8B
2026-01
Revenue YoY Growth
-0.04%
YoY Comparison
Gross Margin
+0.07%
Latest Quarter
Free Cash Flow
$615954000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ACM Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E is elevated at 30.74x, while the forward P/E is substantially lower at 12.71x; this wide gap implies the market expects a significant recovery in earnings over the next twelve months, likely pricing in a rebound from the depressed Q1 results. Compared to sector averages, AECOM's trailing P/E of 30.74x trades at a premium, though direct industry comps are not provided in the data; its Price-to-Sales ratio of 1.07 and EV/Sales of 0.83 appear reasonable for a capital-light services business, suggesting the market is applying a discount on sales due to margin concerns. Historically, the current trailing P/E of 30.74x is below the peak levels seen in recent quarters (e.g., 42.33x in Q1 FY2026) but remains above the multi-year average, indicating that while the stock has fallen, valuation compression has not been absolute as earnings have fallen faster, leaving the multiple still reflective of some recovery hopes.
PE
30.7x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -22x~3300x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on the alarming contraction in profitability and revenue. The Q1 net margin of 1.95% is less than half the year-ago period's 4.16%, and gross margin fell sequentially, suggesting cost inflation or unfavorable project mix is eroding the core business. While the debt-to-equity ratio of 1.35 is manageable, the sharp sequential drop in operating cash flow from $196.1 million in Q4 to $70.2 million in Q1 raises liquidity concerns if the downturn persists. The primary risk is that the company fails to achieve the analyst-forecasted EPS recovery to $7.52, leaving the stock overvalued on a trailing basis.
Market & Competitive Risks are heightened by the stock's valuation disconnect. A trailing P/E of 30.74x is a premium multiple for a company in decline, creating substantial compression risk if growth does not re-accelerate. The stock's beta of 1.085 suggests it is slightly more volatile than the market, yet its -45.15 relative strength over one year shows extreme idiosyncratic underperformance, indicating it is being treated as a company-specific story rather than a macro play. Sector rotation away from industrials or further delays in global infrastructure spending could prolong the downturn.
The Worst-Case Scenario involves the Q1 weakness proving structural, not cyclical. A continuation of revenue declines and margin compression would lead to missed analyst estimates, multiple compression, and a breach of the $79.01 technical support. In this adverse scenario, the stock could realistically re-test its 52-week low, implying a -6.1% downside from the current price. A more severe bear case, factoring in a recessionary environment, could see the stock fall to a P/E of 10x on depressed earnings, targeting the mid-$70s, representing a potential loss of -10% to -15%.
FAQ
The key risks are, in order of severity: 1) Operational Risk: The profitability collapse may be structural, not cyclical, with Q1 net margin of 1.95% potentially becoming the new normal. 2) Growth Risk: Revenue contraction of -4.6% YoY could accelerate if project delays or cancellations mount. 3) Valuation Risk: The high trailing P/E of 30.74x leaves the stock vulnerable to multiple compression if the recovery is delayed. 4) Sentiment Risk: With only one analyst providing coverage and a short ratio of 4.74, the stock is prone to high volatility and negative momentum feeds on itself, as seen in the 40.18% max drawdown.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees a slow recovery, with the stock trading between $90 and $100 as it meets analyst EPS estimates of ~$7.52. The Bull Case (25% probability) involves a swift turnaround, driving the stock to $105-$120 on EPS beats and multiple expansion. The Bear Case (15% probability) entails further deterioration, pushing the stock to re-test its lows between $75 and $85. The most likely outcome is the Base Case, assuming ACM stabilizes its operations but struggles to regain rapid growth momentum in the near term.
ACM sends mixed valuation signals. It is overvalued on a trailing basis, with a P/E of 30.74x on collapsing earnings. However, it appears undervalued on a forward basis, with a P/E of 12.71x pricing in a massive earnings rebound. The Price-to-Sales ratio of 1.07 and EV/Sales of 0.83 are reasonable for the industry. The market is currently paying a fair price for uncertainty—it is not discounting a disaster (hence the low forward multiple) but also not paying for growth. The valuation implies the market expects a significant but not guaranteed recovery in profitability over the next year.
ACM is a speculative buy only for investors with a high risk tolerance and a long-term horizon. The 12.71x forward P/E offers compelling value if the company achieves its forecasted EPS recovery to $7.52, implying significant upside. However, this hinges on reversing a severe 55% Q1 net income decline and a 4.6% revenue contraction. The strong $616M free cash flow provides a margin of safety, but the stock's 37.4% six-month decline reflects justified skepticism. It is a good buy for deep-value contrarians who believe the operational setback is temporary, but unsuitable for conservative investors seeking stability.
ACM is strictly a long-term investment with a minimum suggested holding period of 12-18 months. The investment thesis is based on a cyclical earnings recovery that will take multiple quarters to confirm or deny. The stock's high beta (1.085) and extreme recent volatility (-37.4% over 6 months) make it unsuitable for short-term trading, as sentiment swings can be violent and disconnected from incremental news. The negligible dividend yield (0.77%) does not provide income support for waiting. Only investors willing to endure potential further volatility while awaiting fundamental proof of a turnaround should consider a position.